Takeda Pharmaceutical Company Limited Current And Deferred Tax Relating To Items Charged Or Credited Directly To Equity
Takeda Pharmaceutical Company Limited (TKPHF) reported Current And Deferred Tax Relating To Items Charged Or Credited Directly To Equity of JPY 1.35 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity · last filed 2025-06-25
| Period end | Current And Deferred Tax Relating To Items Charged Or Credited Directly To Equity 12 month |
|---|---|
| 2025-03-31 | 1.35B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 506.00M JPY 20-F · filed 2025-06-25 |